Disability changes after treatment of upper limb spasticity with botulinum toxin

Neurorehabilitation and Neural Repair

Volumn 10, Issue 1, 1996, Pages 47-52

  Reiter, Frank ^a   Danni, Maura ^a   Ceravolo, Gabriella M ^a   Provinciali, Leandro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Assessment; Botulinum toxin; Disability; Spasticity

Indexed keywords

EID: 21344452509     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/154596839601000107     Document Type: Article

References (18)

1. World Health Organization. International classification of impairments, disabilities, and handicaps: a manual of classification relating to the consequences of disease. Geneva: WHO, 1980.
2. Das TK, Park DM Botulinum toxin in treating spasticity. Br J Clin Pract 1989;43:401-402.
3. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol 1992;28:512-15.
4. Dengler R., Neyer U., Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic foot drop. J Neurol 1992;239:375-78.
5. Hesse S., Friedrich H, Domasch C, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: Preliminary results. J Rehab Sciences 1992;5:98-101.
6. Hesse S., Luecke D., Malezic M., Bertelt C., Friedrich H, Gregoric M, Mauritz KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-24.
7. Benecke R. Botulinum toxin for spasms and spasticity in the lower extremities. In: Jankovic J, Hallett M (eds.). Therapy with botulinum toxin. New York: Marcel Dekker, 1994:557-66.
8. Tsui JK, O'Brien CF Clinical trials for spasticity. In: Jankovic J, Hallett M (eds.). Therapy with boculinum toxin. New York: Marcel Dekker, 1994:523-35.
9. Dunne JW, Heye N., Dunne SL Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995; 58:232-35.
10. Grazko MA, Polo KB, Jabbari B. 1 Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-17.
11. Wade DT Measurement in neurologic rehabilitation. New York: Oxford University Press, 1992.
12. Bohannon RW, Smith MB Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206.
13. Daniels L., Worthingham C. Muscle testing: techniques of manual examination, 5th ed. Philadelphia: W.B. Saunders, 1986.
14. Collin C., Wade DT Assessing motor impairment after stroke: A pilot reliability study. J Neurol Neurosurg Psychiatry 1990;53:576-79.
15. Wade DT, Langton-Hewer R., Wood VA, Skinbeck CE, Ismail IM. The hemiplegic arm after stroke: Measurement and recovery. J Neurol Neurosurg Psychiatry 1983;46:521-24.
16. Granger CV, Hamilton BB, Sherwin FS Guide for the use of the uniform data set for medical rehabilitation. Uniform Data System for Medical Rehabilitation Project Office, Buffalo General Hospital, New York, 1986.
17. Hunt SM, McKenna SP, McEwan J. A quantitative approach to perceived health status: A validation study. J Epidemiol Community Health 1980;34:281-86.
18. Ebrahim S., Barer D., Nouri F. Use of the Nottingham Health Profile with patients after stroke. J Epidemiol Community Health 1986;39:86-89.